S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

NASDAQ:MTFB - MOTIF BIO PLC/S Stock Price, Forecast & News

$0.10
0.00 (0.00 %)
(As of 12/16/2019)
Today's Range
$0.10
Now: $0.11
$0.12
50-Day Range
$0.11
MA: $0.11
$0.11
52-Week Range
$0.08
Now: $0.11
$11.50
Volume867,698 shs
Average VolumeN/A
Market Capitalization$1.56 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.32
Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTFB
CUSIPN/A
Phone212-210-6248

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.60) per share

Profitability

Miscellaneous

Employees7
Market Cap$1.56 million
Next Earnings Date4/20/2020 (Estimated)
OptionableNot Optionable

Receive MTFB News and Ratings via Email

Sign-up to receive the latest news and ratings for MTFB and its competitors with MarketBeat's FREE daily newsletter.


MOTIF BIO PLC/S (NASDAQ:MTFB) Frequently Asked Questions

What is MOTIF BIO PLC/S's stock symbol?

MOTIF BIO PLC/S trades on the NASDAQ under the ticker symbol "MTFB."

When is MOTIF BIO PLC/S's next earnings date?

MOTIF BIO PLC/S is scheduled to release their next quarterly earnings announcement on Monday, April 20th 2020. View Earnings Estimates for MOTIF BIO PLC/S.

What price target have analysts set for MTFB?

2 analysts have issued 1 year price targets for MOTIF BIO PLC/S's stock. Their forecasts range from $5.00 to $5.00. On average, they expect MOTIF BIO PLC/S's stock price to reach $5.00 in the next year. This suggests a possible upside of 4,661.9% from the stock's current price. View Analyst Price Targets for MOTIF BIO PLC/S.

What is the consensus analysts' recommendation for MOTIF BIO PLC/S?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MOTIF BIO PLC/S in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for MOTIF BIO PLC/S.

What are Wall Street analysts saying about MOTIF BIO PLC/S stock?

Here are some recent quotes from research analysts about MOTIF BIO PLC/S stock:
  • 1. According to Zacks Investment Research, "Motif Bio plc is a biopharmaceutical company. It engaged in the research and development of antibiotics for serious and life-threatening infections caused by multi-drug resistant bacteria. The company's product pipeline includes Iclaprim, REVIVE-1 and REVIVE-2 which are in clinical stage. Motif Bio plc is headquartered in London, UK. " (8/8/2019)
  • 2. Northland Securities analysts commented, "We anticipate the Co. to provide guidance on iclaprim’s path forward in June. Key Points Motif Completes $3.55MM Raise: Pre-open, Motif announced that it has completed placement of 45MM ordinary shares priced at 6 pence, raising gross proceeds of £2.7MM (~$3.55MM USD) providing the Company with additional working capital. The offering, if translated into ADS equivalents, would approximate 2.5MM ADS shares at $1.58 per share. Through FDA Update: The net proceeds from the offering, combined with existing cash resources, and adjusted for repayment of $0.5MM to Hercules Capital, approximate $5- $5.5MM. We anticipate cash balances to be sufficient to fund operations beyond its receipt of minutes anticipated in early-June from the May 3rd Type A meeting with the FDA." (3/26/2019)

Has MOTIF BIO PLC/S been receiving favorable news coverage?

News stories about MTFB stock have trended extremely negative on Tuesday, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. MOTIF BIO PLC/S earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for MOTIF BIO PLC/S.

Who are some of MOTIF BIO PLC/S's key competitors?

What other stocks do shareholders of MOTIF BIO PLC/S own?

Who are MOTIF BIO PLC/S's key executives?

MOTIF BIO PLC/S's management team includes the folowing people:
  • Dr. Graham George Lumsden, CEO & Exec. Director (Age 59)
  • Mr. Jonathan E. Gold, CFO & Exec. Director (Age 46)
  • Dr. David B. Huang, Chief Medical Officer (Age 44)
  • Mr. Robert Dickey IV, Advisor (Age 63)
  • Laurie Doyle, Head of Investor Relations & Corp. Communications

When did MOTIF BIO PLC/S IPO?

(MTFB) raised $17 million in an IPO on Friday, November 18th 2016. The company issued 2,400,000 shares at $6.98 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

How do I buy shares of MOTIF BIO PLC/S?

Shares of MTFB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is MOTIF BIO PLC/S's stock price today?

One share of MTFB stock can currently be purchased for approximately $0.11.

How big of a company is MOTIF BIO PLC/S?

MOTIF BIO PLC/S has a market capitalization of $1.56 million. The company earns $-13,980,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. MOTIF BIO PLC/S employs 7 workers across the globe.View Additional Information About MOTIF BIO PLC/S.

What is MOTIF BIO PLC/S's official website?

The official website for MOTIF BIO PLC/S is http://www.motifbio.com/.

How can I contact MOTIF BIO PLC/S?

MOTIF BIO PLC/S's mailing address is 201 TEMPLE CHAMBERS 3-7 TEMPLE AVENUE, LONDON X0, EC4Y0DT. The company can be reached via phone at 212-210-6248 or via email at [email protected]


MarketBeat Community Rating for MOTIF BIO PLC/S (NASDAQ MTFB)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  231 (Vote Outperform)
Underperform Votes:  265 (Vote Underperform)
Total Votes:  496
MarketBeat's community ratings are surveys of what our community members think about MOTIF BIO PLC/S and other stocks. Vote "Outperform" if you believe MTFB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel